Distribution of scores for Rett syndrome patients (no. 13), Angelman syndrome patients (no. 16), Mowat–Wilson syndrome patients (no. 14), patients with a negative TCF4 molecular test (no. 60), and PTHS patients with a proven TCF4 alteration (no. 18), using the proposed clinical scoring system (already presented in “Marangi et al16).